Literature DB >> 2125009

Identification of sites for alkylation by N-ethylmaleimide and pertussis toxin-catalyzed ADP-ribosylation on GTP-binding proteins.

S Hoshino1, S Kikkawa, K Takahashi, H Itoh, Y Kaziro, H Kawasaki, K Suzuki, T Katada, M Ui.   

Abstract

An alpha beta gamma-trimeric GTP-binding protein (Go) serving as the substrate of pertussis toxin-(IAP) catalyzed ADP-ribosylation was purified from rat brain membranes. The constituent alpha-subunit (alpha o) was alkylated with N-ethylmaleimide (NEM), and the functionally important sulfhydryl groups were investigated. There were at least two cysteine residues highly reactive to NEM on the GDP-bound form of alpha o. These alkylations resulted in loss of its ability to be ADP-ribosylated by IAP and to associate with beta gamma, but leaving the GTP-binding site of alpha o intact. The reacted cysteine residues were identified by the sequencing of tryptic fragments of alpha o. One of the alkylation sites was Cys-351, which was four amino acid residues away from the carboxyl-terminus of the molecule. The Cys-351 was proven to be also a site for IAP-catalyzed ADP-ribosylation. Possible roles of cysteine residues on the alpha-subunit of Go are discussed in the functions of the signal transducing protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125009     DOI: 10.1016/0014-5793(90)80548-w

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Tonic inhibition and rebound facilitation of a neuronal calcium channel by a GTP-binding protein.

Authors:  H Kasai
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

Review 2.  ADP-ribosyltransferases and poly ADP-ribosylation.

Authors:  Chao Liu; Xiaochun Yu
Journal:  Curr Protein Pept Sci       Date:  2015       Impact factor: 3.272

3.  Structure-function analyses of a pertussis-like toxin from pathogenic Escherichia coli reveal a distinct mechanism of inhibition of trimeric G-proteins.

Authors:  Dene R Littler; Sheng Y Ang; Danilo G Moriel; Martina Kocan; Oded Kleifeld; Matthew D Johnson; Mai T Tran; Adrienne W Paton; James C Paton; Roger J Summers; Mark A Schembri; Jamie Rossjohn; Travis Beddoe
Journal:  J Biol Chem       Date:  2017-06-29       Impact factor: 5.157

4.  A1 adenosine receptors inhibit multiple voltage-gated Ca2+ channel subtypes in acutely isolated rat basolateral amygdala neurons.

Authors:  B A McCool; J S Farroni
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

5.  Mutation of cysteine 214 in Gi1 alpha subunit abolishes its endogenous GTPase activity.

Authors:  Yuren Wang; Gregory Tawa; Deborah Smith; Girija Krishnamurthy; Kathleen H Young
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

6.  Inosine induces presynaptic inhibition of acetylcholine release by activation of A3 adenosine receptors at the mouse neuromuscular junction.

Authors:  A R Cinalli; J F Guarracino; V Fernandez; L I Roquel; A S Losavio
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

7.  G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization.

Authors:  Sean A Diehl; Benjamin McElvany; Rajkumar Noubade; Nathan Seeberger; Brock Harding; Karen Spach; Cory Teuscher
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

8.  Arachidonic Acid Activates K-Cl-cotransport in HepG2 Human Hepatoblastoma Cells.

Authors:  Yong Soo Lee
Journal:  Korean J Physiol Pharmacol       Date:  2009-10-31       Impact factor: 2.016

9.  Arf-1 (ADP-ribosylation factor-1) is involved in the activation of a mammalian Na+-selective current.

Authors:  Sebastian Straube; Anant B Parekh
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

10.  The role of poly ADP-ribosylation in the first wave of DNA damage response.

Authors:  Chao Liu; Aditi Vyas; Muzaffer A Kassab; Anup K Singh; Xiaochun Yu
Journal:  Nucleic Acids Res       Date:  2017-08-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.